Shares of Victrex plc (LON:VCT – Get Free Report) have received a consensus recommendation of “Hold” from the seven analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is GBX 662.86.
A number of equities research analysts recently issued reports on VCT shares. JPMorgan Chase & Co. decreased their price objective on shares of Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a report on Wednesday, March 18th. Berenberg Bank decreased their price target on shares of Victrex from GBX 695 to GBX 600 and set a “hold” rating for the company in a report on Tuesday, June 9th. Jefferies Financial Group decreased their price target on shares of Victrex from GBX 675 to GBX 595 and set a “hold” rating for the company in a report on Tuesday, May 12th. Canaccord Genuity Group cut shares of Victrex to a “buy” rating and set a GBX 725 price target for the company. in a report on Friday, May 15th. Finally, UBS Group restated a “sell” rating and set a GBX 575 price target on shares of Victrex in a report on Monday, May 11th.
View Our Latest Stock Analysis on Victrex
Victrex Trading Up 0.3%
Victrex (LON:VCT – Get Free Report) last issued its quarterly earnings data on Monday, May 11th. The company reported GBX 17.20 earnings per share (EPS) for the quarter. The firm had revenue of £147.10 million during the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. Analysts expect that Victrex will post 73.1078905 EPS for the current fiscal year.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
- Five stocks we like better than Victrex
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
